News: Infectious Diseases
Read the latest news from the College of Natural Sciences at The University of Texas at Austin
UT News
Texas Biologics to Bolster Research in Therapeutics
A new University of Texas at Austin initiative will focus primarily on biologic research and development.
UT Austin Leads in New Summary of Top “Degrees of the Future”
A new report releases what the nation’s best degrees of the future are.
Dried Bacteria Could Revolutionize Testing, Laboratory Science
What if there were a way to make proteins, enzymes and reagents right in the lab, in small amounts, on demand?
Frog Pandemic
Frogs are also struggling through their own pandemic that has several eerie parallels with COVID-19.
Texas Scientist
UT Austin Harnesses Power of Biology in Partnership with Army Research Laboratory
Inside the "biological foundry" at the Army Research Lab's ARL-South partnership on the campus of UT Austin
Department of Molecular Biosciences
Breakthrough in Fight on Tick-Borne CCHF Virus is Latest Use of New Strategy Against Diseases
Scientists are developing vaccines and other treatments for the tick-borne Crimean-Congo hemorrhagic fever (CCHF)
McLellan Honored for Contributions to COVID-19 Vaccines
Jason McLellan, UT Austin molecular biosciences professor, has received the 2021 Shirley Bird Perry Longhorn Citizenship Award
Department of Molecular Biosciences
'Last Resort' Antibiotic Pops Bacteria Like Balloons
A new study reveals that colistin, a last resort antibiotic “punches holes in bacteria, causing them to pop like balloons.”
Department of Molecular Biosciences
Our Immune Systems Blanket the SARS-CoV-2 Spike Protein with Antibodies
Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD
Department of Molecular Biosciences
Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.